AU2018330848A1 - Bacteriophage for modulating inflammatory bowel disease - Google Patents

Bacteriophage for modulating inflammatory bowel disease

Info

Publication number
AU2018330848A1
AU2018330848A1 AU2018330848A AU2018330848A AU2018330848A1 AU 2018330848 A1 AU2018330848 A1 AU 2018330848A1 AU 2018330848 A AU2018330848 A AU 2018330848A AU 2018330848 A AU2018330848 A AU 2018330848A AU 2018330848 A1 AU2018330848 A1 AU 2018330848A1
Authority
AU
Australia
Prior art keywords
bacteriophage
inflammatory bowel
bowel disease
modulating inflammatory
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018330848A
Other languages
English (en)
Inventor
Koji Atarashi
Hava BEN DAVID
Eran Elinav
Kenya Honda
Efrat KHABRA
Yulia MUTIUHIN
Seiko Narushima
Sarah Pollock
Rotem Sorek
Eyal WEINSTOCK
Naomi Zak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Biomx Ltd
Keio University
Original Assignee
Yeda Research and Development Co Ltd
Biomx Ltd
Keio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd, Biomx Ltd, Keio University filed Critical Yeda Research and Development Co Ltd
Publication of AU2018330848A1 publication Critical patent/AU2018330848A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2018330848A 2017-09-08 2018-09-07 Bacteriophage for modulating inflammatory bowel disease Abandoned AU2018330848A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762555790P 2017-09-08 2017-09-08
US62/555,790 2017-09-08
PCT/IB2018/001128 WO2019048930A2 (en) 2017-09-08 2018-09-07 BACTERIOPHAGE OF MODULATION OF INFLAMMATORY INTESTINAL DISEASE

Publications (1)

Publication Number Publication Date
AU2018330848A1 true AU2018330848A1 (en) 2020-03-12

Family

ID=64316588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018330848A Abandoned AU2018330848A1 (en) 2017-09-08 2018-09-07 Bacteriophage for modulating inflammatory bowel disease

Country Status (7)

Country Link
US (1) US20220031776A1 (enExample)
EP (2) EP3678639B1 (enExample)
JP (1) JP2020533408A (enExample)
CN (1) CN111801107A (enExample)
AU (1) AU2018330848A1 (enExample)
CA (1) CA3074406A1 (enExample)
WO (1) WO2019048930A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112469426B (zh) * 2018-05-23 2025-07-11 布莱阿姆青年大学 噬菌体组合物和试剂盒及相关方法
US11986502B2 (en) 2018-05-23 2024-05-21 Optium, LLC Bacteriophage compositions and kits and related methods
CA3131316A1 (en) 2019-03-07 2020-09-10 Keio University Bacteriophage for modulating inflammatory bowel disease
US20240075084A1 (en) * 2021-01-21 2024-03-07 Biomx Ltd. Klebsiella bacteriophage and uses thereof
US20250281553A1 (en) * 2021-04-22 2025-09-11 Ferring B.V. Bacteriophage therapy against adherent-invasive escherichia coli
CN115558650B (zh) * 2022-10-09 2023-05-30 优宜邦生物科技(上海)有限公司 一种宽宿主谱变栖克雷伯氏菌噬菌体及其应用和制剂
CN118318913A (zh) * 2024-05-09 2024-07-12 江苏省农业科学院 一种含有噬菌体的新型饲料添加剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2799063A1 (en) * 2013-04-30 2014-11-05 Ferring B.V. Bacteriophage therapy
CN106754745B (zh) * 2016-11-29 2020-07-14 江苏省农业科学院 一种肺炎克雷伯氏菌噬菌体及其应用

Also Published As

Publication number Publication date
EP3678639B1 (en) 2022-02-16
CA3074406A1 (en) 2019-03-14
EP4032526A1 (en) 2022-07-27
WO2019048930A2 (en) 2019-03-14
US20220031776A1 (en) 2022-02-03
CN111801107A (zh) 2020-10-20
JP2020533408A (ja) 2020-11-19
EP3678639A2 (en) 2020-07-15
WO2019048930A3 (en) 2019-04-18

Similar Documents

Publication Publication Date Title
AU2018330848A1 (en) Bacteriophage for modulating inflammatory bowel disease
ZA202311311B (en) Anti-bcma heavy chain-only antibodies
WO2019099682A9 (en) Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains
MX2024014319A (es) Anticuerpos anti-bcma unicamente de cadena pesada
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
EP4361281A3 (en) Acidophilic fusarium oxysporum strains, methods of their production and methods of their use
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
MY188541A (en) Besifloxacin for the treatment of resistant acne
EP4620519A3 (en) Methods and compositions relating to chondrisomes from blood products
EP4516319A3 (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
MX2017016529A (es) Composiciones que comprenden cepas bacterianas.
EP4293033A3 (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
EP4417262A3 (en) Combination therapy
WO2018081502A8 (en) Synthetic bacteriophages and bacteriophage compositions
WO2016014434A3 (en) Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodies
EP4233880A3 (en) Hnf4a sarna compositions and methods of use
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
WO2017147130A3 (en) Direct fed microbial for prevention of shrimp disease
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period